Ann M. Hanly, Chief Technology Officer at Vir Biotechnology, Inc. (VIR), sold 5,254 shares at $22.77 ($120K) on 2023-03-30, disclosed to the SEC on 2023-03-31.
Open-market sale of $120k VIR by Chief Technology Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.77 | 2,627 | $60K | 50.0% |
| 2 | $22.77 | 2,627 | $60K | 50.0% |
| Total | $22.77 avg | 5,254 | $120K | 100% |
| Filing → |
| VIR | SELL | 2024-02-26 | $247K | — | Filing → |
| VIR | SELL | 2023-02-24 | $120K | — | Filing → |
| VIR | SELL | 2022-03-31 | $138K | — | Filing → |